Associated Medical Professionals of New York

Syracuse, New York 13210

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma in Situ, Non-muscle Invasive Bladder Cancer, Prostate Cancer, Transitional Cell Carcinoma

Studies at this site

• A Registry for Hereditary Cancer Risk Assessment and Genetic Testing — Completed
• Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder — Stopped early